{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T04:46:33Z","timestamp":1784090793380,"version":"3.55.0"},"reference-count":100,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003093","name":"Malaysia Ministry of Higher Education","doi-asserted-by":"publisher","award":["FRGS\/1\/2023\/STG04\/UNIKL\/02\/2"],"award-info":[{"award-number":["FRGS\/1\/2023\/STG04\/UNIKL\/02\/2"]}],"id":[{"id":"10.13039\/501100003093","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["T2394502"],"award-info":[{"award-number":["T2394502"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22207103"],"award-info":[{"award-number":["22207103"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ejmech.2025.118225","type":"journal-article","created":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T06:55:32Z","timestamp":1759906532000},"page":"118225","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["An insight into the synthesis, structure-activity relationships, and bioactivity of synthetic small molecule ligands targeting toll-like receptor 4"],"prefix":"10.1016","volume":"301","author":[{"given":"Siti Nor \u2018Izzah","family":"Normizan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongshuang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kok Wai","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajibul","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poh Yen","family":"Khor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"187","key":"10.1016\/j.ejmech.2025.118225_bib1","first-page":"1","article-title":"Toll-like receptors activation, signaling, and targeting: an overview","volume":"43","author":"El-zayat","year":"2019","journal-title":"Bull. Natl. Res. Cent."},{"issue":"11","key":"10.1016\/j.ejmech.2025.118225_bib2","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1084\/jem.189.11.1777","article-title":"MD-2, a molecule that confers lipopolysaccharide responsiveness on toll-like receptor 4","volume":"189","author":"Shimazu","year":"1999","journal-title":"J. Exp. Med."},{"issue":"7242","key":"10.1016\/j.ejmech.2025.118225_bib3","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/nature07830","article-title":"The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex","volume":"458","author":"Park","year":"2009","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.ejmech.2025.118225_bib4","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1038\/emm.2013.97","article-title":"Recognition of lipopolysaccharide pattern by TLR4 complexes","volume":"45","author":"Park","year":"2013","journal-title":"Exp. Mol. Med."},{"issue":"30","key":"10.1016\/j.ejmech.2025.118225_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1073\/pnas.2105316118","article-title":"Sulfatides are endogenous ligands for the TLR4\u2013MD-2 complex","volume":"118","author":"Su","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"8","key":"10.1016\/j.ejmech.2025.118225_bib6","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1172\/JCI62423","article-title":"Alarmins: awaiting a clinical response","volume":"122","author":"Chan","year":"2012","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118225_bib7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/imr.12577","article-title":"Alarmins and immunity","volume":"280","author":"Yang","year":"2017","journal-title":"Immunol. Rev."},{"issue":"2","key":"10.1016\/j.ejmech.2025.118225_bib8","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/01.shk.0000225404.51320.82","article-title":"HMGB1 signals through toll-like receptor (TLR) 4 and TLR2","volume":"26","author":"Yu","year":"2006","journal-title":"Shock"},{"issue":"21","key":"10.1016\/j.ejmech.2025.118225_bib9","first-page":"1","article-title":"Exploring the biological functional mechanism of the HMGB1\/TLR4\/MD-2 complex by surface plasmon resonance","volume":"24","author":"He","year":"2018","journal-title":"Mol Med"},{"key":"10.1016\/j.ejmech.2025.118225_bib10","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1189\/jlb.1008644","article-title":"Nucleophosmin may act as an alarmin : implications for severe sepsis","volume":"86","author":"Nawa","year":"2009","journal-title":"J. Leukoc. Biol."},{"issue":"19","key":"10.1016\/j.ejmech.2025.118225_bib11","first-page":"1","article-title":"Nucleophosmin : from structure and function to disease development","volume":"17","author":"Box","year":"2016","journal-title":"BMC Mol. Biol."},{"issue":"33","key":"10.1016\/j.ejmech.2025.118225_bib12","doi-asserted-by":"crossref","first-page":"11187","DOI":"10.1523\/JNEUROSCI.0684-12.2012","article-title":"Opioid activation of toll-like receptor 4 contributes to drug reinforcement","volume":"32","author":"Hutchinson","year":"2012","journal-title":"J. Neurosci."},{"issue":"16","key":"10.1016\/j.ejmech.2025.118225_bib13","doi-asserted-by":"crossref","first-page":"6325","DOI":"10.1073\/pnas.1200130109","article-title":"Morphine activates neuroinflammation in a manner parallel to endotoxin","volume":"109","author":"Wang","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA."},{"issue":"4","key":"10.1016\/j.ejmech.2025.118225_bib14","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1021\/acs.jcim.7b00717","article-title":"Dissecting the innate immune recognition of opioid iInactive isomer (+)-Naltrexone derived toll-like receptor 4 (TLR4) antagonists","volume":"58","author":"Zhang","year":"2018","journal-title":"J. Chem. Inf. Model."},{"issue":"10","key":"10.1016\/j.ejmech.2025.118225_bib15","doi-asserted-by":"crossref","first-page":"4812","DOI":"10.1021\/acs.jmedchem.6b00177","article-title":"Discovery and structure-activity relationships of the neoseptins: a new class of toll-like Receptor-4 (TLR4) agonists","volume":"59","author":"Berger","year":"2016","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2025.118225_bib16","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s43450-023-00491-7","article-title":"Phytochemical small molecules as potential anti - angiogenesis targeted therapy for triple - negative breast cancer","volume":"3","author":"Poh-Yen","year":"2023","journal-title":"Rev Bras Farmacogn"},{"issue":"August","key":"10.1016\/j.ejmech.2025.118225_bib17","first-page":"1","article-title":"Recent progress on small molecule TLR4 antagonist against triple-negative breast cancer progression and complications","volume":"116","author":"Ramana","year":"2024","journal-title":"Bioorg. Med. Chem."},{"issue":"3","key":"10.1016\/j.ejmech.2025.118225_bib18","first-page":"853","article-title":"Paving the way for small-molecule drug discovery","volume":"13","author":"Ma","year":"2021","journal-title":"Am J Transl Res"},{"issue":"1","key":"10.1016\/j.ejmech.2025.118225_bib19","first-page":"1","article-title":"Improving targeted small molecule drugs to overcome chemotherapy resistance","volume":"7","author":"Rismanbaf","year":"2024","journal-title":"Cancer Rep"},{"issue":"11704","key":"10.1016\/j.ejmech.2025.118225_bib20","first-page":"1","article-title":"Insights on the synthesis of asymmetric curcumin derivatives and their biological activities","volume":"183","author":"Khor","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"3","key":"10.1016\/j.ejmech.2025.118225_bib21","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1111\/j.1476-5381.2012.01854.x","article-title":"Inhibition of high glucose-induced inflammatory response and macrophage infiltration by a novel curcumin derivative prevents renal injury in diabetic rats","volume":"166","author":"Pan","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118225_bib22","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.ejmech.2014.11.054","article-title":"Design, synthesis and biological activity of novel asymmetric C66 analogs as anti-inflammatory agents for the treatment of acute lung injury","volume":"94","author":"Yu","year":"2015","journal-title":"Eur. J. Med. Chem."},{"issue":"October","key":"10.1016\/j.ejmech.2025.118225_bib23","article-title":"Inhibition of MD2 by natural product-drived JM-9 attenuates renal inflammation and diabetic nephropathy in mice","volume":"168","author":"Wang","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"3","key":"10.1016\/j.ejmech.2025.118225_bib24","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1124\/jpet.115.222570","article-title":"Curcumin analog L48H37 prevents lipopolysaccharide-induced TLR4 signaling pathway activation and sepsis via targeting MD2","volume":"353","author":"Wang","year":"2015","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"11","key":"10.1016\/j.ejmech.2025.118225_bib25","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1016\/j.bmc.2013.03.057","article-title":"Discovery and evaluation of piperid-4-one-containing mono-carbonyl analogs of curcumin as anti-inflammatory agents","volume":"21","author":"Wu","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118225_bib26","first-page":"1","article-title":"Curcumin analogue CA15 exhibits anticancer effects on HEp-2 cells via targeting NF-\u03baB","author":"Chen","year":"2017","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.ejmech.2025.118225_bib27","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ejmech.2018.02.008","article-title":"New MD2 inhibitors derived from curcumin with improved anti-inflammatory activity","volume":"148","author":"Zhang","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118225_bib28","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.ejmech.2019.02.042","article-title":"Design and synthesis novel di-carbonyl analogs of curcumin (DACs) act as potent anti-inflammatory agents against LPS-induced acute lung injury (ALI)","volume":"167","author":"Qian","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"16","key":"10.1016\/j.ejmech.2025.118225_bib29","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.1016\/j.bmc.2016.06.016","article-title":"2-Benzoyl-6-benzylidenecyclohexanone analogs as potent dual inhibitors of acetylcholinesterase and butyrylcholinesterase","volume":"24","author":"Leong","year":"2016","journal-title":"Bioorg. Med. Chem."},{"issue":"5","key":"10.1016\/j.ejmech.2025.118225_bib30","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.ejmech.2018.08.039","article-title":"Asymmetrical meta-methoxylated diarylpentanoids: rational design, synthesis and anti-cancer evaluation in-vitro","volume":"157","author":"Leong","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"12","key":"10.1016\/j.ejmech.2025.118225_bib31","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1007\/s00044-017-2025-4","article-title":"Suppression of PGE2 production via disruption of MAPK phosphorylation by unsymmetrical dicarbonyl curcumin derivatives","volume":"26","author":"Mohd","year":"2017","journal-title":"Med. Chem. Res."},{"issue":"September","key":"10.1016\/j.ejmech.2025.118225_bib32","article-title":"Synthesis of small molecules targeting paclitaxel-induced MyD88 expression in triple-negative breast cancer cell lines","volume":"49","author":"Khor","year":"2021","journal-title":"Bioorg. Med. Chem."},{"issue":"23","key":"10.1016\/j.ejmech.2025.118225_bib33","doi-asserted-by":"crossref","first-page":"8110","DOI":"10.1021\/jm200946h","article-title":"Evaluation and discovery of novel synthetic chalcone derivatives as anti-inflammatory agents","volume":"54","author":"Wu","year":"2011","journal-title":"J. Med. Chem."},{"issue":"17","key":"10.1016\/j.ejmech.2025.118225_bib34","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.1111\/bph.13221","article-title":"MD-2 as the target of a novel small molecule, L6H21, in the attenuation of LPS-induced inflammatory response and sepsis","volume":"172","author":"Wang","year":"2015","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118225_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40001-023-01630-5","article-title":"Chalcone-derivative L6H21 attenuates the OVA-induced asthma by targeting MD2","volume":"29","author":"Ge","year":"2024","journal-title":"Eur. J. Med. Res."},{"issue":"3","key":"10.1016\/j.ejmech.2025.118225_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2020.166043","article-title":"Myeloid differentiation protein 2 mediates angiotensin II-induced inflammation and mesenchymal transition in vascular endothelium","volume":"1867","author":"Qian","year":"2021","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"issue":"April","key":"10.1016\/j.ejmech.2025.118225_bib37","first-page":"1","article-title":"Discovery of new MD2 inhibitor from chalcone derivatives with anti-inflammatory effects in LPS-induced acute lung injury","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.ejmech.2025.118225_bib38","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/jcmm.13017","article-title":"Targeting myeloid differentiation protein 2 by the new chalcone L2H21 protects LPS-induced acute lung injury","volume":"21","author":"Zhang","year":"2017","journal-title":"J. Cell Mol. Med."},{"issue":"887","key":"10.1016\/j.ejmech.2025.118225_bib39","first-page":"1","article-title":"Curcumin analogs reduce stress and inflammation indices in experimental models of diabetes","volume":"10","author":"Biswas","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118225_bib40","doi-asserted-by":"crossref","first-page":"887","DOI":"10.2147\/DDDT.S160314","article-title":"Design, synthesis, and structure-activity relationships of 2-benzylidene-1-indanone derivatives as anti-inflammatory agents for treatment of acute lung injury","volume":"12","author":"Xiao","year":"2018","journal-title":"Drug Des. Dev. Ther."},{"issue":"August","key":"10.1016\/j.ejmech.2025.118225_bib41","first-page":"76","article-title":"Chalcone derivatives ameliorate lipopolysaccharide-induced acute lung injury and in fl ammation by targeting MD2","volume":"43","author":"Zhang","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejmech.2025.118225_bib42","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1111\/bph.12091","article-title":"Suppression of toll-like receptor 4 activation by caffeic acid phenethyl ester is mediated by interference of LPS binding to MD2","volume":"168","author":"Kim","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118225_bib43","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ejmech.2017.11.066","article-title":"Discovery of caffeic acid phenethyl ester derivatives as novel myeloid differentiation protein 2 inhibitors for treatment of acute lung injury","volume":"143","author":"Chen","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"March","key":"10.1016\/j.ejmech.2025.118225_bib44","article-title":"Novel O -benzylcinnamic acid derivative L26 treats acute lung injury in mice by MD-2","volume":"252","author":"Li","year":"2023","journal-title":"Eur. J. Med. Chem."},{"issue":"10","key":"10.1016\/j.ejmech.2025.118225_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0164632","article-title":"A novel class of small molecule agonists with preference for human over mouse TLR4 activation","volume":"11","author":"Marshall","year":"2016","journal-title":"PLoS One"},{"issue":"February","key":"10.1016\/j.ejmech.2025.118225_bib46","first-page":"1","article-title":"Pentamidine alleviates inflammation and lipopolysaccharide-induced sepsis by inhibiting TLR4 activation via targeting MD2","volume":"13","author":"Wu","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118225_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113731","article-title":"Identification, semisynthesis, and anti-inflammatory evaluation of 2,3-seco-clavine-type ergot alkaloids from human intestinal fungus Aspergillus fumigatus CY018","volume":"224","author":"Zhang","year":"2021","journal-title":"Eur. J. Med. Chem."},{"issue":"5","key":"10.1016\/j.ejmech.2025.118225_bib48","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/bph.13394","article-title":"Pharmacological characterization of the opioid inactive isomers (+)-naltrexone and (+)-naloxone as antagonists of toll-like receptor 4","volume":"173","author":"Wang","year":"2016","journal-title":"Br. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.ejmech.2025.118225_bib49","doi-asserted-by":"crossref","first-page":"10503","DOI":"10.1021\/acs.jmedchem.5c01250","article-title":"RIPTACs for precision cancer therapy: a novel modality with the inspiration of HLD-0915 as the first candidate in clinical trials","volume":"68","author":"Ma","year":"2025","journal-title":"J. Med. Chem."},{"issue":"7","key":"10.1016\/j.ejmech.2025.118225_bib50","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1096\/fj.12-222992","article-title":"Rifampin inhibits toll-like receptor 4 signaling by targeting myeloid differentiation protein 2 and attenuates neuropathic pain","volume":"27","author":"Wang","year":"2013","journal-title":"FASEB J."},{"issue":"4","key":"10.1016\/j.ejmech.2025.118225_bib51","first-page":"3127","article-title":"Exploring the function of (+)-Naltrexone precursors: their activity as TLR4 antagonists and potential in treating morphine addiction","volume":"67","author":"Gao","year":"2024","journal-title":"J. Phys. Chem. A"},{"key":"10.1016\/j.ejmech.2025.118225_bib52","doi-asserted-by":"crossref","first-page":"5273","DOI":"10.1021\/acs.jcim.4c00692","article-title":"Dissecting the role of the hydroxyl moiety at C14 in (+)-opioid-based TLR4 antagonists via wet-lab experiments and molecular dynamics simulations","volume":"64","author":"Gao","year":"2024","journal-title":"J. Chem. Inf. Model."},{"issue":"3","key":"10.1016\/j.ejmech.2025.118225_bib53","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/jnc.15302","article-title":"Artemisinin inhibits TLR4 signaling by targeting co-receptor MD2 in microglial BV-2 cells and prevents lipopolysaccharide-induced blood-brain barrier leakage in mice","volume":"157","author":"Zhang","year":"2021","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118225_bib54","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.intimp.2014.07.001","article-title":"Dihydroartemisinin inhibits activation of the Toll-like receptor 4 signaling pathway and production of type i interferon in spleen cells from lupus-prone MRL\/lpr mice","volume":"22","author":"Huang","year":"2014","journal-title":"Int. Immunopharmacol."},{"issue":"758","key":"10.1016\/j.ejmech.2025.118225_bib55","first-page":"1","article-title":"Design, synthesis and cytotoxicity of novel dihydroartemisinin-coumarin hybrids via click chemistry","volume":"21","author":"Tian","year":"2016","journal-title":"Molecules"},{"issue":"1672","key":"10.1016\/j.ejmech.2025.118225_bib56","first-page":"1","article-title":"Design, synthesis, and mechanism of mihydroartemisinin \u2013 coumarin hybrids as potential anti-neuroinflammatory agents","volume":"24","author":"Yu","year":"2019","journal-title":"Molecules"},{"issue":"March","key":"10.1016\/j.ejmech.2025.118225_bib57","article-title":"Structure-activity relationship study of dihydroartemisinin C-10 hemiacetal derivatives as toll-like receptor 4 antagonists","volume":"114","author":"Wang","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118225_bib58","doi-asserted-by":"crossref","first-page":"5453","DOI":"10.1021\/acs.jmedchem.9b00316","article-title":"Discovery of 3-(Indol-5-yl)-indazole derivatives as novel myeloid differentiation protein 2\/Toll-like receptor 4 antagonists for treatment of acute lung injury","volume":"62","author":"Liu","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118225_bib59","doi-asserted-by":"crossref","first-page":"4206","DOI":"10.1021\/jm301694x","article-title":"Identification of substituted pyrimido[5,4-b] indoles as selective Toll- like receptor 4 ligands","volume":"56","author":"Ligands","year":"2013","journal-title":"J. Med. Chem."},{"issue":"7","key":"10.1016\/j.ejmech.2025.118225_bib60","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1021\/acs.bioconjchem.5c00076","article-title":"Design and application of conjugatable small molecule toll-like receptor 4 ligands yutaro mahara","volume":"36","author":"Mahara","year":"2025","journal-title":"Bioconjug. Chem."},{"issue":"21","key":"10.1016\/j.ejmech.2025.118225_bib61","doi-asserted-by":"crossref","first-page":"4931","DOI":"10.1016\/j.bmcl.2014.09.039","article-title":"Discovery of substituted 4-aminoquinazolines as selective toll-like receptor 4 ligands","volume":"24","author":"Nour","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"February","key":"10.1016\/j.ejmech.2025.118225_bib62","article-title":"Design , synthesis and anti-rheumatoid arthritis evaluation of double-ring conjugated enones","volume":"109","author":"Zhou","year":"2021","journal-title":"Bioorg. Chem."},{"issue":"August","key":"10.1016\/j.ejmech.2025.118225_bib63","article-title":"Synthesis, activity and mechanism for double-ring conjugated enones","volume":"49","author":"Zhou","year":"2021","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2025.118225_bib64","doi-asserted-by":"crossref","first-page":"44065","DOI":"10.1021\/acsomega.2c05492","article-title":"Design and synthesis of novel double-ring conjugated enones as potent anti-rheumatoid arthritis agents","volume":"7","author":"Zhou","year":"2022","journal-title":"ACS Omega"},{"issue":"August 2023","key":"10.1016\/j.ejmech.2025.118225_bib65","article-title":"Design, synthesis and anti-rheumatoid arthritis activity of target TLR4 inhibitors","volume":"97","author":"Wang","year":"2024","journal-title":"Bioorg. Med. Chem."},{"issue":"December 2018","key":"10.1016\/j.ejmech.2025.118225_bib66","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ejps.2019.04.016","article-title":"Aryl quinolinyl hydrazone derivatives as anti-inflammatory agents that inhibit TLR4 activation in the macrophages","volume":"134","author":"Debnath","year":"2019","journal-title":"Eur. J. Pharmaceut. Sci."},{"issue":"104455","key":"10.1016\/j.ejmech.2025.118225_bib67","article-title":"Design , synthesis and biological evaluation of novel arylpropionic esters for the treatment of acute kidney injury","volume":"105","author":"Zuo","year":"2020","journal-title":"Bioorg. Chem."},{"issue":"March","key":"10.1016\/j.ejmech.2025.118225_bib68","first-page":"1","article-title":"Arylacryl amides: design, synthesis and the protection against cisplatin-induced acute kidney injury via TLR4\/STING\/NF-\u03baB pathway","volume":"146","author":"Wu","year":"2024","journal-title":"Bioorg. Chem."},{"issue":"5","key":"10.1016\/j.ejmech.2025.118225_bib69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms22052527","article-title":"A novel 1,8-naphthyridine-2-carboxamide derivative attenuates inflammatory responses and cell migration in lps-treated bv2 cells via the suppression of ros generation and tlr4\/myd88\/nf-\u03bab signaling pathway","volume":"22","author":"Nguyen","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"21","key":"10.1016\/j.ejmech.2025.118225_bib70","doi-asserted-by":"crossref","first-page":"5218","DOI":"10.1016\/j.bmcl.2016.09.060","article-title":"Synthesis and anti-inflammatory activity of paeonol analogues in the murine model of complete Freund \u2019 s adjuvant induced arthritis","volume":"26","author":"Huang","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"June","key":"10.1016\/j.ejmech.2025.118225_bib71","article-title":"Synthesis and anti-inflammatory activity of paeonol derivatives with etherized aryl urea by regulating TLR4\/MyD88 signaling pathway in RAW264.7 cell","volume":"127","author":"Gong","year":"2022","journal-title":"Bioorg. Chem."},{"issue":"19","key":"10.1016\/j.ejmech.2025.118225_bib72","doi-asserted-by":"crossref","first-page":"4048","DOI":"10.1016\/j.tet.2007.02.127","article-title":"Convenient synthesis of antisepsis agent TAK-242 by novel optical resolution through diastereomeric N-acylated sulfonamide derivative","volume":"63","author":"Nishiguchi","year":"2007","journal-title":"Tetrahedron"},{"issue":"1","key":"10.1016\/j.ejmech.2025.118225_bib73","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ejphar.2008.01.026","article-title":"TAK-242 selectively suppresses toll-like receptor 4-signaling mediated by the intracellular domain","volume":"584","author":"Kawamoto","year":"2008","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.ejmech.2025.118225_bib74","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1124\/mol.105.019695","article-title":"A novel cyclohexene derivative, ethyl (6R)-6-[N-(2-chloro-4-fluorophenyl) sulfamoyl]cyclohex-1-ene-1-carboxylate (TAK-242), selectively inhibits toll-like receptor 4-mediated cytokine production through suppression of intracellular signaling","volume":"69","author":"Ii","year":"2006","journal-title":"Mol. Pharmacol."},{"issue":"7","key":"10.1016\/j.ejmech.2025.118225_bib75","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1111\/j.1476-5381.2009.00297.x","article-title":"Analysis of binding site for the novel small-molecule TLR4 signal transduction inhibitor TAK-242 and its therapeutic effect on mouse sepsis model","volume":"157","author":"Takashima","year":"2009","journal-title":"Br. J. Pharmacol."},{"issue":"April","key":"10.1016\/j.ejmech.2025.118225_bib76","article-title":"Synthesis and evaluation of the anti-inflammatory activity of novel 8-quinolinesulfonamide derivatives as TLR4\/MD-2 inhibitors with efficacy in adjuvant-induced arthritis","volume":"114","author":"Liu","year":"2021","journal-title":"Bioorg. Chem."},{"issue":"624059","key":"10.1016\/j.ejmech.2025.118225_bib77","first-page":"1","article-title":"Specific TLR4 blocking effect of a novel 3,4-Dihydropyrimidinone derivative","volume":"11","author":"Zhou","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118225_bib78","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3762\/bjoc.10.25","article-title":"Secondary amine-initiated three-component synthesis of 3,4- dihydropyrimidinones and thiones involving alkynes, aldehydes and thiourea\/urea","volume":"10","author":"Wan","year":"2014","journal-title":"Beilstein J. Org. Chem."},{"issue":"19","key":"10.1016\/j.ejmech.2025.118225_bib79","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1039\/b901112a","article-title":"Chemo-\/regioselective synthesis of 6-unsubstituted dihydropyrimidinones, 1,3-thiazines and chromones via novel variants of Biginelli reaction","author":"Wan","year":"2009","journal-title":"Chem. Commun."},{"issue":"113713","key":"10.1016\/j.ejmech.2025.118225_bib80","first-page":"1","article-title":"1,10-Seco-Eudesmane sesquiterpenoids as a new type of anti-neuroinflammatory agents by suppressing TLR4\/NF-\u03baB\/MAPK pathways","volume":"224","author":"Tang","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118225_bib81","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ejmech.2018.05.033","article-title":"Discovery of novel small molecule TLR4 inhibitors as potent anti-inflammatory agents","volume":"154","author":"Xu","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118225_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.139375","article-title":"Discovery of 3-bromoflavone derivative D5 as a novel TLR4-MD2 antagonist for the treatment of acute lung injury and sepsis","author":"Cheng","year":"2024","journal-title":"J. Mol. Struct."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118225_bib83","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23010102","article-title":"Rational design of a new class of toll-like receptor 4 (TLR4) tryptamine related agonists by means of the structure-and ligand-based virtual screening for vaccine adjuvant discovery","volume":"23","author":"Honegr","year":"2018","journal-title":"Molecules"},{"issue":"7","key":"10.1016\/j.ejmech.2025.118225_bib84","doi-asserted-by":"crossref","first-page":"E884","DOI":"10.1073\/pnas.1525639113","article-title":"TLR4\/MD-2 activation by a synthetic agonist with no similarity to LPS","volume":"113","author":"Wang","year":"2016","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"12","key":"10.1016\/j.ejmech.2025.118225_bib85","doi-asserted-by":"crossref","first-page":"9309","DOI":"10.1039\/D3CP06124H","article-title":"Dissecting the chiral recognition of TLR4\/MD2 with Neoseptin-3 enantiomers by molecular dynamics simulations","volume":"26","author":"Zhang","year":"2024","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.ejmech.2025.118225_bib86","article-title":"Dissecting the species-specific recognition of Neoseptin 3 by TLR4\/MD2 via molecular dynamics simulations","volume":"827","author":"Wu","year":"2023","journal-title":"Phys. Chem. Chem. Phys."},{"issue":"13","key":"10.1016\/j.ejmech.2025.118225_bib87","doi-asserted-by":"crossref","first-page":"4659","DOI":"10.1021\/jm2003365","article-title":"Development of beta-amino alcohol derivatives that inhibit Toll-like receptor 4 mediated inflammatory response as potential antiseptics","volume":"54","author":"Chavez","year":"2011","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2025.118225_bib88","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1074\/jbc.275.4.2251","article-title":"Mouse Toll-like receptor 4\u00b7MD-2 complex mediates lipopolysaccharide-mimetic signal transduction by Taxol","volume":"275","author":"Kawasaki","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118225_bib89","first-page":"1","article-title":"Structural insight into TLR4\/MD-2 activation by synthetic LPS mimetics with distinct binding modes","volume":"16","author":"Fu","year":"2025","journal-title":"Nat. Commun."},{"issue":"22","key":"10.1016\/j.ejmech.2025.118225_bib90","doi-asserted-by":"crossref","first-page":"15052","DOI":"10.1074\/jbc.M901429200","article-title":"Essential roles of hydrophobic residues in both MD-2 and toll-like receptor 4 in activation by endotoxin","volume":"284","author":"Resman","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.ejmech.2025.118225_bib91","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1021\/acs.jcim.9b01143","article-title":"Combinatorial effect of ligand and ligand-binding site hydrophobicities on binding affinity","volume":"60","author":"Sriramulu","year":"2020","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2025.118225_bib92","series-title":"Verified Market Reports","year":"2025"},{"issue":"April","key":"10.1016\/j.ejmech.2025.118225_bib93","first-page":"1","article-title":"TLR4 is one of the receptors for Chikungunya virus envelope protein E2 and regulates virus induced pro-inflammatory responses in host macrophages","volume":"14","author":"Mahish","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejmech.2025.118225_bib94","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/icb.2017.5","article-title":"Dengue virus NS1 protein activates immune cells via TLR4 but not TLR2 or TLR6","volume":"95","author":"Stacey","year":"2017","journal-title":"Immunol. Cell Biol."},{"issue":"304","key":"10.1016\/j.ejmech.2025.118225_bib95","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa3863","article-title":"Dengue virus NS1 protein activates cells via toll-like receptor 4 and disrupts endothelial cell monolayer integrity","volume":"7","author":"Modhiran","year":"2015","journal-title":"Sci. Transl. Med."},{"issue":"4","key":"10.1016\/j.ejmech.2025.118225_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111562","article-title":"Activation of toll-like receptor 4 by Ebola virus-shed glycoprotein is direct and requires the internal fusion loop but not glycosylation","volume":"41","author":"Scherm","year":"2022","journal-title":"Cell Rep."},{"issue":"September","key":"10.1016\/j.ejmech.2025.118225_bib97","first-page":"1","article-title":"Activation of TLR4 by viral glycoproteins: a double-edged sword?","volume":"13","author":"Halajian","year":"2022","journal-title":"Front. Microbiol."},{"issue":"8","key":"10.1016\/j.ejmech.2025.118225_bib98","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.3109\/13693786.2010.481292","article-title":"Absence of functional TLR4 impairs response of macrophages after Candida albicans infection","volume":"48","author":"Gasparoto","year":"2010","journal-title":"Med. Mycol."},{"issue":"9","key":"10.1016\/j.ejmech.2025.118225_bib99","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.immuni.2022.08.015","article-title":"Fooling TLR4 to promote fungal virulence","volume":"55","author":"Le\u00f3n","year":"2022","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.ejmech.2025.118225_bib100","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/sji.12105","article-title":"TLR2 and TLR4 in Cutaneous Leishmaniasis caused by Leishmania major","volume":"78","author":"Tolouei","year":"2013","journal-title":"Scand. J. Immunol."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425009900?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425009900?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T13:05:49Z","timestamp":1773147949000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425009900"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":100,"alternative-id":["S0223523425009900"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118225","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An insight into the synthesis, structure-activity relationships, and bioactivity of synthetic small molecule ligands targeting toll-like receptor 4","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118225","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118225"}}